Introduction Cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) are among the most common chronic diseases and often coexist, with about 30 % of patients with T2DM experiencing CVD
However, because of their lesser magnitude of glucose lowering, they are prescribed more commonly as an addition to another type of medicine rather than as monotherapy: Metformin: First-line therapy that decreases hepatic glucose output
Mental health, focus, and productivity A new world opens up when the mind stops buzzing about food all day
Participants randomized to retatrutide initiated treatment with 2 mg once-weekly and increased the dose in a step-wise approach every four weeks until reaching the target dose of 4 mg (via one step at 2 mg), 9 mg (via steps at 2 mg, 4 mg and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg and 9 mg)
Proper reconstitution helps preserve peptide integrity while reducing unnecessary variability between experiments
D.RogersT